Type 2 Diabetes Connect
  • Saved

Patients with systemic lupus erythematosus and lupus nephritis showed significantly higher risk of hypertension, hyperlipidemia, and type 2 diabetes compared with those without lupus nephritis.

  • Saved

This synopsis focuses on outpatient management of diabetes with high risk of hypoglycemia; the guideline also addresses prevention of hypoglycemia in hospitalized patients.

  • Saved
Incidence of Type 2 Diabetes, Cardiovascular Disease and Chronic Kidney Disease in Patients With Multiple Sclerosis Initiating Disease-Modifying Therapies: Retrospective Cohort Study Using a Frequentist Model Averaging Statistical Framework

Incidence of Type 2 Diabetes, Cardiovascular Disease and Chronic Kidney Disease in Patients With Multiple Sclerosis Initiating Disease-Modifying Therapies: Retrospective Cohort Study Using a Frequentist Model Averaging Statistical Framework

Source : https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0300708

Researchers are increasingly using insights derived from large-scale, electronic healthcare data to inform drug development and provide human validation of novel treatment pathways and aid in drug repurposing/repositioning. The objective...

A positive but nonsignificant trend was observed among patients treated with dimethyl fumarate toward a decreased incidence of type 2 diabetes, CVD, and CKD relative to other disease-modifying therapies.

  • Saved
Serum T50 Predicts Cardiovascular Mortality in Individuals With Type 2 Diabetes: a Prospective Cohort Study

Serum T50 Predicts Cardiovascular Mortality in Individuals With Type 2 Diabetes: a Prospective Cohort Study

Source : https://pubmed.ncbi.nlm.nih.gov/38528373/

Serum T50 improves prediction of cardiovascular and all-cause mortality risk in individuals with T2D. Serum T50 may be useful for risk stratification and to guide therapeutic strategies aiming to reduce...

Serum T50 may be useful for risk stratification and to guide therapeutic strategies aiming to reduce CV mortality in type 2 diabetes.

  • Saved
Patients' Perceptions of Artificial Intelligence in a Deep Learning-Assisted Diabetic Retinopathy Screening Event: a Real-World Assessment

Patients' Perceptions of Artificial Intelligence in a Deep Learning-Assisted Diabetic Retinopathy Screening Event: a Real-World Assessment

Source : https://pubmed.ncbi.nlm.nih.gov/38404014/

During an artificial intelligence (AI)-assisted diabetic retinopathy screening event, we performed a survey on patients´ perceptions on AI. Respondents were individuals with diabetes, mostly followed in primary healthcare with a...

Although nearly 50% of participants reported that they knew what artificial intelligence (AI) was, only 14% reported having good or expert knowledge of AI but most said they felt positive about it in health care.